OFIX News and Press, Orthofix Medical Inc. From 07/13/22

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and LimaCorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, today announced a licensing partnership for the U.S. market to...

Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing benefits of the nucleus-annulus design of the M 6-C disc Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device comp...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in the upcoming UBS Global Healthcare investor con...

Orthofix Medical Inc. (OFIX) Q1 2022 Earnings Conference Call May 6, 2022, 8:30 AM ET Company Participants Jon Serbousek – Director, President and Chief Executive Officer Doug Rice – Chief Financial Officer Alexa Huerta – Senior Director of Investor Relations and Finance ...

Orthofix press release (NASDAQ:OFIX): Q1 GAAP EPS of -$0.22 misses by $0.12. Revenue of $106.4M (+0.8% Y/Y) beats by $1.93M. For further details see: Orthofix GAAP EPS of -$0.22 misses by $0.12, revenue of $106.4M beats by $1.93M

Net sales of $106.4 million, an increase of 1% on a reported basis and 2% on a constant currency basis over prior year New product sales drive solid growth in Biologics, Spinal Implants, and Orthopedics FDA grants PMA for AccelStim™ bone growth stimu...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device. The AccelStim device pr...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the renewal and expansion of its partnership agreement with MTF Biologics – a global nonprofit organization that saves and heals lives by honoring donated...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the first quarter 2022 before market open on Friday, May 6, 2022. Jon Serbousek, President and Chief Executive Officer,...

Medical device company, Orthofix Medical (OFIX +0.1%), announced on Monday that the U.S. Food and Drug Administration (FDA) issued 510(k) clearance for its TrueLok EVO Ring Fixation System. TrueLok EVO is a circular fixator designed for limb reconstruction and deformity correction procedures,...